vs
ALTISOURCE PORTFOLIO SOLUTIONS S.A.（ASPS）与RECURSION PHARMACEUTICALS, INC.（RXRX）财务数据对比。点击上方公司名可切换其他公司
ALTISOURCE PORTFOLIO SOLUTIONS S.A.的季度营收约是RECURSION PHARMACEUTICALS, INC.的1.2倍（$42.3M vs $35.5M），ALTISOURCE PORTFOLIO SOLUTIONS S.A.净利率更高（-16.8% vs -304.2%，领先287.4%），RECURSION PHARMACEUTICALS, INC.同比增速更快（681.7% vs 3.2%），ALTISOURCE PORTFOLIO SOLUTIONS S.A.自由现金流更多（$-525.0K vs $-47.3M），过去两年RECURSION PHARMACEUTICALS, INC.的营收复合增速更高（60.5% vs 3.6%）
Altisource Portfolio Solutions S.A.是面向抵押贷款、房地产及消费金融领域的全球服务商，为贷款机构、服务商、投资者等市场参与者提供技术、数据与运营解决方案，优化资产管理、房产交易等业务流程，提升客户运营效率。
Recursion Pharmaceuticals是一家临床阶段生物技术企业，依托人工智能技术和高通量生物实验体系，开发针对罕见病、肿瘤、炎症性疾病等领域未满足医疗需求的创新疗法，核心市场覆盖北美，与全球多家生物制药企业合作推进在研管线落地。
ASPS vs RXRX — 直观对比
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $42.3M | $35.5M |
| 净利润 | $-7.1M | $-108.1M |
| 毛利率 | 26.5% | 59.8% |
| 营业利润率 | -15.5% | -304.8% |
| 净利率 | -16.8% | -304.2% |
| 营收同比 | 3.2% | 681.7% |
| 净利润同比 | 18.2% | 39.6% |
| 每股收益（稀释后） | $-1.02 | $-0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $42.3M | $35.5M | ||
| Q3 25 | $41.9M | $5.2M | ||
| Q2 25 | $43.3M | $19.2M | ||
| Q1 25 | $43.4M | $14.7M | ||
| Q4 24 | $41.0M | $4.5M | ||
| Q3 24 | $40.5M | $26.1M | ||
| Q2 24 | $39.1M | $14.4M | ||
| Q1 24 | $39.5M | $13.8M |
| Q4 25 | $-7.1M | $-108.1M | ||
| Q3 25 | $-2.3M | $-162.3M | ||
| Q2 25 | $16.7M | $-171.9M | ||
| Q1 25 | $-5.3M | $-202.5M | ||
| Q4 24 | $-8.7M | $-178.9M | ||
| Q3 24 | $-9.3M | $-95.8M | ||
| Q2 24 | $-8.3M | $-97.5M | ||
| Q1 24 | $-9.2M | $-91.4M |
| Q4 25 | 26.5% | 59.8% | ||
| Q3 25 | 27.1% | -183.8% | ||
| Q2 25 | 30.1% | -4.9% | ||
| Q1 25 | 30.7% | -48.0% | ||
| Q4 24 | 30.3% | -181.4% | ||
| Q3 24 | 29.8% | 53.7% | ||
| Q2 24 | 32.5% | 36.2% | ||
| Q1 24 | 31.2% | 19.1% |
| Q4 25 | -15.5% | -304.8% | ||
| Q3 25 | 1.2% | -3327.6% | ||
| Q2 25 | 7.5% | -916.8% | ||
| Q1 25 | 7.5% | -1297.9% | ||
| Q4 24 | 1.4% | -4042.4% | ||
| Q3 24 | 2.7% | -377.1% | ||
| Q2 24 | 5.3% | -697.4% | ||
| Q1 24 | -1.4% | -698.4% |
| Q4 25 | -16.8% | -304.2% | ||
| Q3 25 | -5.5% | -3135.3% | ||
| Q2 25 | 38.5% | -894.2% | ||
| Q1 25 | -12.1% | -1373.3% | ||
| Q4 24 | -21.3% | -3935.5% | ||
| Q3 24 | -23.0% | -367.5% | ||
| Q2 24 | -21.1% | -676.6% | ||
| Q1 24 | -23.2% | -662.4% |
| Q4 25 | $-1.02 | $-0.17 | ||
| Q3 25 | $-0.22 | $-0.36 | ||
| Q2 25 | $1.48 | $-0.41 | ||
| Q1 25 | $-0.09 | $-0.50 | ||
| Q4 24 | $-4.72 | $-0.56 | ||
| Q3 24 | $-2.61 | $-0.34 | ||
| Q2 24 | $-2.33 | $-0.40 | ||
| Q1 24 | $-0.33 | $-0.39 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $26.6M | $743.3M |
| 总债务越低越好 | $191.1M | $9.6M |
| 股东权益账面价值 | $-110.2M | $1.1B |
| 总资产 | $139.8M | $1.5B |
| 负债/权益比越低杠杆越低 | — | 0.01× |
8季度趋势，按日历期对齐
| Q4 25 | $26.6M | $743.3M | ||
| Q3 25 | $28.6M | $659.8M | ||
| Q2 25 | $30.0M | $525.1M | ||
| Q1 25 | $30.8M | $500.5M | ||
| Q4 24 | $29.8M | $594.4M | ||
| Q3 24 | $28.3M | $427.6M | ||
| Q2 24 | $29.7M | $474.3M | ||
| Q1 24 | $29.6M | $296.3M |
| Q4 25 | $191.1M | $9.6M | ||
| Q3 25 | $192.5M | $11.9M | ||
| Q2 25 | $193.9M | $14.2M | ||
| Q1 25 | $195.0M | $16.4M | ||
| Q4 24 | $230.5M | $19.0M | ||
| Q3 24 | — | $20.5M | ||
| Q2 24 | — | $22.9M | ||
| Q1 24 | — | — |
| Q4 25 | $-110.2M | $1.1B | ||
| Q3 25 | $-104.2M | $1.0B | ||
| Q2 25 | $-102.7M | $919.1M | ||
| Q1 25 | $-119.8M | $933.9M | ||
| Q4 24 | $-157.4M | $1.0B | ||
| Q3 24 | $-149.4M | $524.6M | ||
| Q2 24 | $-140.8M | $584.4M | ||
| Q1 24 | $-133.3M | $401.2M |
| Q4 25 | $139.8M | $1.5B | ||
| Q3 25 | $139.9M | $1.4B | ||
| Q2 25 | $142.9M | $1.3B | ||
| Q1 25 | $145.7M | $1.3B | ||
| Q4 24 | $143.6M | $1.4B | ||
| Q3 24 | $144.5M | $726.5M | ||
| Q2 24 | $146.6M | $775.9M | ||
| Q1 24 | $148.9M | $557.8M |
| Q4 25 | — | 0.01× | ||
| Q3 25 | — | 0.01× | ||
| Q2 25 | — | 0.02× | ||
| Q1 25 | — | 0.02× | ||
| Q4 24 | — | 0.02× | ||
| Q3 24 | — | 0.04× | ||
| Q2 24 | — | 0.04× | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-505.0K | $-46.1M |
| 自由现金流经营现金流 - 资本支出 | $-525.0K | $-47.3M |
| 自由现金流率自由现金流/营收 | -1.2% | -133.1% |
| 资本支出强度资本支出/营收 | 0.0% | 3.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-5.1M | $-378.3M |
8季度趋势，按日历期对齐
| Q4 25 | $-505.0K | $-46.1M | ||
| Q3 25 | $718.0K | $-117.4M | ||
| Q2 25 | $-306.0K | $-76.4M | ||
| Q1 25 | $-5.0M | $-132.0M | ||
| Q4 24 | $-1.4M | $-115.4M | ||
| Q3 24 | $-1.6M | $-59.2M | ||
| Q2 24 | $180.0K | $-82.2M | ||
| Q1 24 | $-2.2M | $-102.3M |
| Q4 25 | $-525.0K | $-47.3M | ||
| Q3 25 | $697.0K | $-117.6M | ||
| Q2 25 | $-309.0K | $-79.6M | ||
| Q1 25 | $-5.0M | $-133.8M | ||
| Q4 24 | $-1.4M | $-116.7M | ||
| Q3 24 | — | $-63.8M | ||
| Q2 24 | — | $-83.4M | ||
| Q1 24 | — | $-109.0M |
| Q4 25 | -1.2% | -133.1% | ||
| Q3 25 | 1.7% | -2272.5% | ||
| Q2 25 | -0.7% | -413.9% | ||
| Q1 25 | -11.5% | -907.4% | ||
| Q4 24 | -3.4% | -2567.7% | ||
| Q3 24 | — | -244.6% | ||
| Q2 24 | — | -578.5% | ||
| Q1 24 | — | -789.9% |
| Q4 25 | 0.0% | 3.5% | ||
| Q3 25 | 0.1% | 4.7% | ||
| Q2 25 | 0.0% | 16.4% | ||
| Q1 25 | 0.1% | 12.4% | ||
| Q4 24 | 0.0% | 28.6% | ||
| Q3 24 | 0.0% | 17.5% | ||
| Q2 24 | 0.0% | 8.2% | ||
| Q1 24 | 0.0% | 48.2% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | -0.02× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASPS
| Services | $39.9M | 94% |
| Revenue Relatedto Technology Platformsand Professional Services | $2.4M | 6% |
RXRX
暂无分部数据
